YusufBaran
ABSTRACTS PUBLISHED IN INTERNATIONAL CONFERENCES
2016
Baran Y. Outcomes of Targeting BCR/ABL Tyrosine Kinase Protein for the Treatment of Chronic Myeloid Leukemia. Annual General Meeting of The World Academy of Sciences, 12-16 November 2016, Kigali, Rwanda.
2016
Baran Y. Sphingolipid Metabolism and Signaling in the regulation of drug resistance in chronic myeloid leukemia. 4th International Drug Design Congress, 12-14 October 2016, İstanbul, Turkey
2016
Baran Y. Molecular Mechanisms of Drug Resistance in Hematological Malignancies. 16th Asian Science Council, 30 May-2 June 2016, Colombo, Sri Lanka.
2016
Baran Y. Sphingolipid Signaling in the Regulation of Drug Resistance in Chronic Myeloid Leukemia. 4th International Conference of Young Scientists & Annual General Meeting of the Global Young Academy, 25-29 May 2016, Eindhoven, Holland
2015
Kiraz Y, Adan A, Baran Y. Multidrug Resistance Mechanisms in Hematological Malignancies. TWAS Regional Office for Central & South Asia (TWAS-ROCASA), At: Jawaharlal Nehru Centre for Advanced Scientific Research, 21-22 December 2015, Bangalure, India
2015
Baran Y. Molecular Mechanisms of Drug Resistance in cancer. Annual General Meeting of The World Academy of Sciences, 18-22 November 2015, Vienna, Austria.
2015
Kiraz Y, Adan A, Baran Y. Multidrug Resistance Mechanisms in Leukemias. International Future of Biomedicine Meeting, 2-7 September 2015, Vladivastok, Russia
2015
Kacı N, Kiraz Y, Baran Y. Synergistic apoptotic effects of bortezomib and methylstat on different multiple myeloma cell lines. 20th Congress of European Hematology Association 11-14 June 2015, Vienna, Austria (PB1850).
2015
Kiraz Y, Saydam G, SAhin F, Kozanoglu I, Ozdogu H, Piskin O, Ozcan MA, Avcu F, Ural AU, Unal A, Baran Y. Expression levels of Jak/STAT signaling genes in newly diagnosed drug sensitive and resistant chronic myeloid leukemia patients. 20th. Congress of European Hematology Association, 11-14 June 2015, Vienna, Australia
2015
Cincin ZB, Kiraz Y, Kıran B, Baran Y, Cakmakoglu B. Anti-proliferative, apoptotic and signal transduction effects of hesperidin in ECC-1 endometrial cancer cells. 5th International Molecular Medicine Congress 20-22 May 2015, İzmir
2015
Attar R, Cincin ZB, Bireller ES, Kiraz Y, Baran Y, Cakmakoglu B Investigation of potential anticarcinogenic effects by corilagin in SKOV-3 ovarian cell line carcinoma. 5th International Molecular Medicine Congress 20-22 May 2015, İzmir.
2015
Rencuzuoglu C, Cincin ZB, Kiraz Y, Baran Y, Cakmakoglu B. Investigation of potential anticarcinogenic effects by corilagin in lung cancer cells. 5th International Molecular Medicine Congress 20-22 May 2015, İzmir.
2015
Cincin ZB, Kiraz Y, Kıran B, Baran Y, Cakmakoglu B. Molecular mechanisms of quercitrin-induced apoptosis in ECC-1 endometrial cancer cell lines. 5th International Molecular Medicine Congress 20-22 May 2015, İzmir.
2015
Gokbulut Adan A, Baran Y. The microarray gene profiling analysis of acute promyelocytic leukemia cells in response to fisetin and hesperetin. Congress of European Hematology Association, 11-14 June 2015, Vienna, Australia (PB1636)
2015
Gokbulut Adan A, Baran Y. Therapeutic Potential of Fisetin and Identification of Its Mechanisms in Action in Chronic Myeloid Leukemia and Acute Promyelocytic Leukemia Cells. 40th FEBS Congress, July 4-9, 2015, Berlin, Germany (Poster)
2015
Gokbulut Adan A, Ogretmen B, Baran Y. Overcoming nilotinib resistance by specific inhibition of sphingosine-1-phosphate receptor 2/gq/phospholipase c axis in chronic myeloid leukemia. 8th International Ceramide Conference (iCC8) and the Sphingolipid Club joint meeting, May 6-10, 2015, Çeşme, Turkey (Poster)
2015
Gokbulut Adan A, Baran Y. A genome-wide analyses of differentially expressed genes and related networks affected by fisetin and hesperetin in chronic myeloid leukemia cells. Congress of European Hematology Association, 11-14 June 2015, Vienna, Australia (PB1734)
2015
Gokbulut Adan A, Ogretmen B, Baran Y. Sphingosine-1-phosphate receptor 2/gq/phospholipase c axis is a novel mechanism to overcome nilotinib resistance in t315i mutation expressing 32dcl3 murine cells. Congress of European Hematology Association, 11-14 June 2015, Vienna, Australia (E1077)
2015
Gokbulut Adan A, Baran Y. Therapeutic Potential of Fisetin and Identification of Its Mechanisms in Action in Chronic Myeloid Leukemia and Acute Promyelocytic Leukemia Cells. 15th annual FEBS Young Scientists’ Forum (YSF) July 2-4, 2015, Berlin, Germany (Poster)
2015
Yandım MK, Kozanoglu I, Ozdogu H, Piskin O, Ozcan MA, Saydam G, Sahin F, Ural AU, Unal A, Baran Y. Discovering Alternative Targets in Chronic Myeloid Leukemia (CML): Determination of Expression Levels of Bioactive Sphingolipid Genes in Newly Diagnosed and Drug-Resistant CML Patients. 20th Congress of European Hematology Association, June 11-14, 2015, Vienna, Austria
2015
Kartal Yandım M, Elmas E, Ceylan C, Baran Y. Antiproliferative and Apoptotic Effects of Ponatinib and its Effects on Macromolecular Changes in Imatinib-Sensitive and –Resistant Chronic Myeloid Leukemia (CML) Cell Lines: A Mechanistic Approach. 20th Congress of European Hematology Association, June 11-14, 2015, Vienna, Austria
2015
Yandım MK, Kozanoglu I, Ozdogu H, Piskin O, Ozcan MA, Saydam G, Sahin F, Ural AU, Unal A, Baran Y. Correlations Between Expression Levels of Bioactive Sphingolipid Genes and Drug-Ssensitivity and –Resistance in Chronic Myeloid Leukemia (CML) Patients. International Ceramide Conference Sphingolipid Club Joint Meeting, 6-10 Mayıs 2015, Çeşme, Türkiye
2014
Yandim MK, Baran Y. Cytotoxic and Cytostatic Effects of Ponatinib on Imatinib-Sensitive and -Resistant Chronic Myeloid Leukemia Cells. 5th International Eurasian Hematology Congress, 15-19 October 2014, Antalya, Turkey
2014
Kiraz Y, Neergheen-Bhujun V, Baran Y. Apoptotic Effects of Non-Edible Parts of Punica Granatum on Human Multiple Myeloma Cells. 5th International Eurasian Hematology Congress, 15-19 October 2014, Antalya, Turkey
2014
- Kiraz Y, Yandim MK, Kozanoglu I, Ozdogu H, Piskin I, Ozcan M, Saydam G, Sahin F, Avcu F, Ural AU, Unal A, Baran Y. JAK/STAT Signaling Pathway Genes in the Regulation of Tyrosine Kinase Inhibitors Induced and Clinical Process in Chronic Myeloid Leukemia Patients. 5th International Eurasian Hematology Congress, 15-19 October 2014, Antalya, Turkey.
2014
Koca D, Hastar N, Baran Y. Inhibition of Jumonji C Domain Containing Histone Demethylases in Acute Myeloid Leukemia. 5th International Eurasian Hematology Congress, 15-19 October 2014, Antalya, Turkey
2014
Gokbulut AA, Ogretmen B, Baran Y. Targeting Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptor 2signalling Pathway to Overcome T315i Mutation in 32dcl3 Cells. 5th International Eurasian Hematology Congress, 15-19 October 2014, Antalya, Turkey.
2014
Gokbulut AA, Baran Y. Cytotoxic and Apoptotic Effects of Fisetin, Hesperetin and Vitexinon Acute Promyelocytic Leukaemia Cells. 5th International Eurasian Hematology Congress, 15-19 October 2014, Antalya, Turkey
2014
Gokbulut AA, Baran Y. Therapeutic Potential of Fisetin, Vitexin and Hesperetin on Chronic Myeloid Leukemia Cells. 5th International Eurasian Hematology Congress, 15-19 October 2014, Antalya, Turkey
2014
Baran Y, Firatligil B, Yandim MK, Kiraz Y, Kozanoglu I, Ozdogu H, Piskin I, Ozcan M, Saydam G, Sahin F, Avcu F, Ural AUU, Unal A. A Novel Biomarker For Drug Resistance In Chronic Myeloid Leukemia: Microrna-17. 5th International Eurasian Hematology Congress, 15-19 October 2014, Antalya, Turkey
2014
Isik S, Karaman M, Baran Y, Kiray M, Caglayan-Sozmen S, Bagriyanik HA, Kozanoglu I, Gokbulut AA, Karaman O, Uzuner N. The effect of mezenchimal stem cells on lung and nasal histopathology and cytokin levels in a murine model of allergic rhinitis. European Academy of Allergy and Clinical Immunology Congress, 7-11 Haziran 2014, Copenhagen, Denmark
2014
Kozanoglu I, Unver G, Sariturk C, Baran Y, Yeral M, Boga C, Ozdogu H. Comparison of Ishage-Based Cd34 (+) Cell Enumeratİon Protocols On Bd Facs Canto II And Attune Flow Cytometers. 40th Annual Meeting of the European Society for Blood and Marrow Transplantation, 30 March – 2 April 2014, Milan, Italy
2013
Tufekci O, Yandim MK, Oren H, Irken G, Baran Y. Targeting FOXM1 Transcription Factor In T-Cell Acute Lymphoblastic Leukemia. 55th Annual Meeting of the American-Society-of-Hematology, 7-10 December 2013, New Orleans, LA, USA
2013
Avcı CB, Kayabasi C, Susluer SY, Balci T, Saydam G, Baran Y, Gunduz C. Ponatinib regulates major signaling pathways in imatinib-resistant chronic myeloid leukemia cells. European Cancer Congress on Reinforcing Multidisciplinarity, 27 September-1 October 2013, Amsterdam, Netherlands
2013
Baran Y, İskender G, Piskin O, Ozcan MA. Determination of the Cytotoxic and Apoptotic Effects of Caffeic Acid Phenethyl Ester and Gossypol in Combination with Fludarabine at a Molecular Level in Acute Lymphoblastic Leukemia Cells. 18th. Congress of European Hematology Association, 13-17 June 2013, Stockholm, Swiss
2013
Baran Y, Gokbulut AA, Cincin ZB, Cakmakoglu B, Kozanoglu I. Changes in Gene Expression Profiles in Response to Apigenin in Imatinib Sensitive and Resistant Chronic Myeloid Leukemia Cells. 18th. Congress of European Hematology Association, 13-17 June 2013, Stockholm, Swiss
2013
Baran Y, Gokbulut AA, Solmaz A, Kozanoglu I, Ozdogu H. Effects of Apigenin on Imatinin-Sensitive And Resistant Chronic Myeloid Leukemia Cells. 18th. Congress of European Hematology Association, 13-17 June 2013, Stockholm, Swiss
2013
Baran Y, Yilmaz S, Cincin ZB, Cakmakoglu B, Kozanoglu I, Ozdogu H. Cytotoxic Effects of Apigenin on Multiple Myeloma Cells. 18th. Congress of European Hematology Association, 13-17 June 2013, Stockholm, Swiss
2013
Baran Y, Yandim MK, Kozanoglu I, Ozdoğu H, Piskin O, Ozcan MA, Saydam G, Sahin F, Avcu F, Ural AU. Diagnostic and Therapeutic Potentials of Expression Levels of Bioactive Sphingolipid Genes in Newly Diagnosed and Drug-Resistant Chronic Myeloid Leukemia Patients. 18th. Congress of European Hematology Association, 13-17 June 2013, Stockholm, Swiss
2013
Katgı A, Gökbulut AA, Sevindik ÖG, Yüksel F, Solmaz SM, Özsan GH, Baran Y, Pişkin O. Effect of Nilotinib on the Function of Carotid Artery Endothelial Cells. 18th. Congress of European Hematology Association, 13-17 June 2013, Stockholm, Swiss
2013
Kozanoglu I, Aygun B, Boga I, Cansun C, Oktar N, Maytalman E, Baran Y, Boga C, Ozdogu H. Immunologically Detection of Bcr/Abl Fusion Protein with Flow Cytometry in K562 Chronic Myeloid Leukemia Cellsand Comparison with RT-PCR Results. 18th. Congress of European Hematology Association, 13-17 June 2013, Stockholm, Swiss
2012
Kayabasi C, Avci CB, Susluer SY, Balci T, Baran Y, Saydam G, Gunduz C. Autophagic and Apoptotic Effects of Tyrosine Kinase Inhibitors in Myeloid Leukemia: Comparison of Three Generation. 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), 8-11 December 2012 Atlanta, USA
2012
Kayabasi C, Avci CB, Susluer SY, Balci T, Baran Y, Saydam G, Gunduz C. Autophagic and Apoptotic Effects of Tyrosine Kinase Inhibitors in Myeloid Leukemia: Comparison of Three Generation. 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), 8-11 December 2012 Atlanta, USA
2012
Kayabasi C, Avci CB, Susluer SY, Balci T, Baran Y, Saydam G, Gunduz C. Autophagic and Apoptotic Effects of Tyrosine Kinase Inhibitors in Myeloid Leukemia: Comparison of Three Generation. 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), 8-11 December 2012 Atlanta, USA
2012
Baran Y, Kartal M, Kozanoğlu İ. A Natural Product, Quercetin Enhances The Cytotoxic And Apoptotic Effects Of Dexamethasone On Jurkat Cells. Haematologica, 17th Congress of European Hematology Association, 14-17 June 2012, Amsterdam, Netherlands
2012
Baran Y, Gökbulut AA, Yasar M. A Novel Agent, KL-21, Has Significant Anticancer Potential On Chronic Lymphocytic Leukemia Cells But Not In Healthy Cells. Haematologica, 17th Congress of European Hematology Association, 14-17 June 2012, Amsterdam, Netherlands
2012
Baran Y, Gökbulut AA, Apohan E, Pişkin O, Ozcan MA. Quercetın Induced Apoptosis In 232b4 Chronic Lymphocytic Leukemia Cells. Haematologica, 17th Congress of European Hematology Association, 14-17 June 2012, Amsterdam, Netherlands
2012
Baran Y, Gökbulut AA, Ozcan MA, Pişkin O, Unlü M. Antiproliferative And Apoptotic Effects Of Resveratrol On Chronic Lymphocytic Leukemia Cells. Haematologica, 17th Congress of European Hematology Association, 14-17 June 2012, Amsterdam, Netherlands.
2012
Baran Y, Turan T, Sanlı-Mohamed G. Changes In Protein Profiles Of Multiple Myeloma Cells In Response To Bortezomib. Haematologica, 17th Congress of European Hematology Association, 14-17 June 2012, Amsterdam, Netherlands
2012
Saydam G, Kiper HD, Tezcanli B, Selvi N, Avci CB, Baran Y, Kosova B, Sahin F. Zoledronate Induces Apoptosis via Effecting on STAT Pathway in Chronic Myeloid Leukemia Cells. Haematologica, 17th Congress of European Hematology Association, 14-17 June 2012, Amsterdam, Netherlands
2012
Sahin F, Purclutepe O, Kiper HD, Tezcanli B, Selvi N, Avci CB, Baran Y, Kosova B, Saydam G, Enalapril Maleate has Cytotoxic Effect in HL60 Leukemic Cells By Altering STAT Signaling Pathway. Haematologica, 17th Congress of European Hematology Association, 14-17 June 2012, Amsterdam, Netherlands
2011
Baran Y, Cakir Z. Combination Of Resveratrol And Nilotinib Inhibits Cell Proliferation And Induce Apoptosis Synergistically In Chronic Myeloid Leukemia Cells. 16th Congress of European Hematology Association, 9-12 June 2011, London, UK
2011
Baran Y, Cakir Z. Determination Of Cytotoxic Effects Of Gossypol On Multiple Myeloma Cells. 16th Congress of European Hematology Association, 9-12 June 2011, London, UK
2011
Baran Y, Sunay O, Çakır Z, Can G, Denek Z, Kozanoğlu I, Yılmaz M. Therapeutic Potentials Of Mesenchymal Stem Cells In Bone Defects, The Case Study In Rabbit Tibia. 16th Congress of European Hematology Association, 9-12 June 2011, London, UK
2011
Baran Y, Camgoz A, Ceylan C. Analyses Of Macromolecules In Nilotinib Resistance By Fourier Transform Infrared Spectroscopy. 16th Congress of European Hematology Association, 9-12 June 2011, London, UK
2011
Baran Y, Camgoz A, Ceylan C. The roles of Macromolecules in Imatinib Resistance in Chronic Myeloid Leukemia. 16th Congress of European Hematology Association, 9-12 June 2011, London, UK
2011
Baran Y, Gencer EB, Güçlüler G. Apoptotic Effects of Sunitinib on Multıple Myeloma Cells. 16th Congress of European Hematology Association, 9-12 June 2011, London, UK
2011
Baran Y, Kozanoglu I, Kartal M, Ozdogu H, Sarıalioglu F. A new indication for an old drug; Therapeutic potential of propranolol on human multiple myeloma cells. 16th Congress of European Hematology Association, 9-12 June 2011, London, UK
2011
Firinci F, Karaman M, Baran Y, Bagriyanik A, Ayyildiz ZA, Kiray M, Kozanoglu I, Yilmaz O, Uzuner N, Karaman O. Mesenchymal Stem Cells Ameliorate The Histopathological Changes In A Murine Model Of Chronic Asthma. 30th Congress of the European Academy of Allergy and Clinical Immunology (EAACI), 11-15 June 2011, Istanbul, Turkey
2011
Gökbulut AA, Kartal M, Yaşar M, Baran Y. A Promising New Anticancer Agent, KL-21, Inhibits Proliferation And Cell Cycle Progression And Induces Apoptosis In Chronic Lymphocytic Leukemia Cells But Has No Effect On Healthy Cells. EACR Anticancer Agents Research Congress. 13-16 October 2011, Antalya, Türkiye
2011
Baran Y, Camgoz A, Ural AU, Avcu F. Molecular Mechanisms Of Nilotinib Resistance And Reversal Of Resistance In Chronic Myeloid Leukemia Cells. 16th Congress of European Hematology Association, 9-12 June 2011, London, UK
2010
Baran Y, Camgoz A, Can G. Changes in Expression Profiles of Apoptosis, Invasion, Metastasis, Angiogenesis, Transcription Factors, Cell Cycle Control and Tumor Supressor Genes in Nilotinib Treated Chronic Myeloid Leukemia Cells. 21st Meeting of European Association for Cancer Research, 26-29 June 2010, Oslo, Norway
2010
Can G, Baran Y. Cytotoxic effects of resveratrol on imatinib sensitive and resistant K562 chronic myeloid leukemia cells. 21st Meeting of the European-Association-for-Cancer-Research 26-29 June 2010, Oslo, Norway
2010
Cakır Z, Baran Y, Can G, Saydam G, Sahin F. Gene Expression Profiles in Resveratrol-Induced Cell Death in Acute Promyelocytic Leukemia Cells. 21st Meeting of European Association for Cancer Research, 26-29 June 2010, Oslo, Norway
2010
Baran Y, Kosova B, Tezcanli B, Ekiz HA, Cakir Z, Selvi N. The roles of STAT transcription Factors in imatinib resistance and sensitivity in BCR/ABL positive chronic myeloid leukemia cells. 21st Meeting of European Association for Cancer Research, 26-29 June 2010, Oslo, Norway
2010
Baran Y, Bassoy EY, Cakir Z, Camgoz A, Gencer EB, Kartal M, Can G, Ekiz HA, Gucluler G. Therapeutic Potential of Targeting Sphingolipid Signaling Pathways in Various Types of Cancers. 21st Meeting of European Association for Cancer Research, 26-29 June 2010, Oslo, Norway
2010
Baran Y, Kartal M, Cakir Z, Saydam G, Sahin F. Ceramides Regulate Resveratrol-Induced Apoptosis In Human Acute Promyelocytic And Chronic Myeloid Leukemia Cells. 15th Congress of European Hematology Association, 10-13 June 2010, Barcelona, Spain
2010
Baran Y, Camgoz A, Gencer EB, Ural AU, Avcu F. A Novel Mechanism Of Nilotinib-Induced Apoptosis; Bioactive Sphingolipids. 15th Congress of European Hematology Association, 10-13 June 2010, Barcelona, Spain
2010
Baran Y, Cakir Z, Can G, Saydam G, Sahin F. Gene Expression Profiles In Resveratrol Applied Acute Promyelocytic Leukemia Cells. 15th Congress of European Hematology Association, 10-13 June 2010, Barcelona, Spain
2010
Baran Y, Kartal M, Can G. Molecular Mechanisms of Resveratrol-Induced Cell Death in K562 Chronic Myeloid Leukemia Cells. 15th Congress of European Hematology Association, 10-13 June 2010, Barcelona, Spain
2010
Baran Y, Kosova B, Tezcanli B, Ekiz HA, Cakir Z, Selvi N. Suppression of STAT5a Increases Chemotherapeutic Sensitivity in Imatinib-Resistant and Imatinib-Sensitive K562 Cells. 15th Congress of European Hematology Association, 10-13 June 2010, Barcelona, Spain
2010
Baran Y, Zincir S, Çakır Z, Ozturk E, Topçu Z. Imatinib-İnduced Apoptosis; A Possible Link To Topoisomerase Enzyme Inhibition. 15th Congress of European Hematology Association, 10-13 June 2010, Barcelona, Spain
2010
Baran Y, Camgoz A, Can G. Expression Analysis Of 84 Genes Involved In Different Signalling Pathways Of Cancer In Chronic Myeloid Leukemia Cells In Response To Nilotinib. Inhibition. 15th Congress of European Hematology Association, 10-13 June 2010, Barcelona, Spain
2010
Can G, Baran Y. Apoptotic Effects Of Resveratrol On Imatinib Sensitve and Resistant Chronic Myeloid Leukemia Cells. 15th Congress of European Hematology Association, 10-13 June 2010, Barcelona, Spain
2009
Goktas S, Ural AU, Baran Y, Yazici S, Aydur E, Avcu F, Pekel A, Dirican B. Beyzadeoglu, M. Proteasome Inhibitor Bortezomib Increases Radiation Sensitivity In Androgen Independent Human Prostate Cancer Cells. 104th Annual Meeting of the American-Urological-Association, 25-30 April 2009, Chicago, IL, USA
2009
Çakır Z, Saydam G, Şahin F, Baran Y. Resveratrol Induces Apoptosis Through Induction of Accumulation of Ceramides in Human HL-60 Acute Premyelocytic Cells. Lipid Signalling and Diseases Congress, 9-15 September 2009, Ortona, Italy, p.40
2009
Baran Y, Güçlüler G. Anticancer Agents Used for the Treatment of Breast Cancer Induces Apoptosis Through Downregulating Antiapoptotic Sphingosine Kinase-1 and Glucosylceramide Synthase Genes in MCF-7 Cells. Lipid Signalling and Diseases Congress, 9-15 September 2009, Ortona, Italy, p.38-39
2009
Gencer EB, Ural AU, Avcu F, Baran Y. Dasatinib induces apoptosis through increasing de novo generation or accumulation of ceramides in human K562 and Meg-01 chronic myeloid leukemia cells. Lipid Signalling and Diseases Congress, 9-15 September 2009, Ortona, Italy, p.46
2009
Baran Y, Can G, Ekiz A. Nilotinib Significantly Induces Apoptosis in Imatinib Resistant K562 Cells, As Effectively As in Parental Sensitive Counterparts. 14th Congress of European Hematology Association, 04-07 June 2009, Berlin, Germany, p.343
2009
Baran Y, Can G, Ekiz A, Genç Ş. Imatinib Induces Autophagy Through Increasing the Expression Levels of Beclin-1 And Atg-5 Genes in Both Parental Sensitive and Imatinib-Resistant K562 Cells. 14th Congress of European Hematology Association, 04-07 June 2009, Berlin, Germany, p.233
2009
Kartal M, Saydam G, Şahin F, Baran Y. Increasing Intracellular Generation or Accumulation of Ceramides Increased Cytotoxic Effects of Resveratrol in Human K562 Chronic Myeloid Leukemia Cells. 14th Congress of European Hematology Association, 04-07 June 2009, Berlin, Germany, p.497
2009
Çakır Z, Saydam G, Şahin F, Baran Y. The Effects of Ceramide, Glucosylceramide and Sphingosine 1 Phosphate in Resveratrol Induced Cell Death in HL60 Acute Promyelocytic Leukemia Cells. 14th Congress of European Hematology Association, 04-07 June 2009, Berlin, Germany, p.540-541
2009
Baran Y, Gencer EB, Ural AU, Avcu F. Increasing De Novo Synthesis of Ceramides Increased Nilotinib Induced Apoptosis in Human Meg-01 Chronic Megacaryoblastic Cells. 14th Congress of European Hematology Association, 04-07 June 2009, Berlin, Germany, p.569.
2009
Gencer EB, Ural AU, Avcu F, Baran Y. Targeting Ceramide Metabolism Increased Sensitivity of Philadelphia Positive Chronic Megacaryoblastic Leukemia Cells to Dasatinib. 14th Congress of European Hematology Association, 04-07 June 2009, Berlin, Germany, p.132.
2009
Baran Y, Gencer EB, Ural AU, Avcu F. Accumulation of Apoptotic Ceramides Increased Apoptotic Effects of Nilotinib in Philadelphia Positive Meg-01 Cells Synergistically. 14th Congress of European Hematology Association, 04-07 June 2009, Berlin, Germany, p.570.
2009
Deveci D, Yüce H, Baran Y. A case Report with Trisomy 8 Mosaicism. 8Pth Balkan Meeting On Human Genetics, 14-17 May 2009, Dubrovnik, Croatia, p.30.
2009
Baran Y, Bassoy EY, Cakir Z. Inhibition of Conversion of Apoptotic Sphingosine Molecule to Antiapoptotic Sphingosine-1-Phosphate Increased Sensitivity of Prostate Cancer Cells to Docetaxel. 8th Balkan Meeting On Human Genetics, 14-17 May 2009, Dubrovnik, Croatia, p.110.
2009
Baran Y, Güçlüler G. The Role Of Sphingosine Kinase-1 Which Converts Apoptotic Sphingosine To Antiapoptotic Sphingosine-1-Phosphate In Docetaxel, Paclitaxel, Doxorubicin, Cyclophosphamide And Tamoxifen Induced Apoptosis In Mcf-7 Breast Cancer Cells. 8th Balkan Meeting On Human Genetics, 14-17 May 2009, Dubrovnik, Croatia, p.110.
2009
Bassoy EY, Kartal M, Baran Y. The Involvement of Glucosyle Ceramide Synthase in Docetaxel-Induced Apoptosis in Human DU-145 and PC-3 Prostate Cancer Cells. 8th Balkan Meeting On Human Genetics, 14-17 May 2009, Dubrovnik, Croatia, p.108-109.
2009
Bassoy EY, Gencer EB, Baran Y. The role of LASS1 gene and ceramide accumulation in docetaxel-induced apoptosis in hormone resistant DU-145 and PC-3 Prostate Cancer Cells. 8th Balkan Meeting On Human Genetics, 14-17 May 2009, Dubrovnik, Croatia, p.111.
2009
Baran Y, Güçlüler G. The Involvement Of Glucosyle Ceramide Synthase Gene On Induction Of Apoptosis In Response To Different Anticancer Agents In Mcf-7 Breast Cancer Cells. 8th Balkan Meeting On Human Genetics, 14-17 May 2009, Dubrovnik, Croatia, p.104.
2008
Durcan C, Seher G, Bassoy EY, Can G, Baran Y. Combination Of Fludarabine And Imatinib-Induced Apoptosis Through Loss Of Mitochondrial Membrane Potential And Caspase-3 Enzyme Activity In Human K562 Chronic Myleloid Leukemia Cells. 32nd World Congress of International Society of Hematology, 19-23 October 2008, Bangkok, Thailand, p.33.
2008
Durcan C, Ural AU, Avcu F, Baran Y. Targeting Conversion Of Apoptotic Ceramide To Antiapoptotic Glucosyle Ceramide Increased Cytotoxic Effects Of Nilotinib In Ph(+) Human Chronic Myeloid Leukemia Cells. 32nd World Congress of International Society of Hematology, 19-23 October 2008, Bangkok, Thailand, p.109.
2008
Bassoy EY, Ozcimen B, Durcan C, Can G, Yusuf B. Inhibition Of Proteasome By Bortezomib Increased Chemosensitivity Of BCR/ABL Positive K562 Human Chronic Myleoid Leukemia Cells To Imatinib. 32nd World Congress of International Society of Hematology, 19-23 October 2008, Bangkok, Thailand, p108.
2008
Durcan C, Ugur AU, Ferit A, Baran Y. Inhibition Of Ceramide Turnover By Glucosyle Ceramide Inhibitor, PDMP, Increased Dasatinib-Induced Apoptosis. 32nd World Congress of International Society of Hematology, 19-23 October 2008, Bangkok, Thailand, p 108.
2008
Gucluler G, Baran Y. Docetaxel Enhances The Cytotoxic Effects Of Imatinib In Philadelphia Positive Human Chronic Myeloid Leukemia Cells. 32nd World Congress of International Society of Hematology, 19-23 October 2008, Bangkok, Thailand, p.32.
2008
Avcu F, Ural AU, Sarper M, Uyuklu T, Baran Y, Safali M, Elçi P. The effects of proteasome inhibitor bortezomib on osteoblast differentiation of human bone marrow derived multipotent mesenchymal stem cells, In Vitro. 14th Annual International Society for Cellular Therapy Meeting, May 17-20 2008, Miami, Florida, USA, p.55.
2007
Uyuklu T, Ural AU, Sarper M, Avcu F, Baran Y, Elci P, Akar N. A Study of Multiple Drug Resistance Mechanisms Improved Against Bortezomib on Multiple Myeloma Cell Lines In Vitro. The 49th American Society of Hematology Annual Meeting and Exposition, December 8-11 2007, Georgia, Atlanta, USA, p.113B.
2006
Baran Y, Salas A, Şenkal CE, Bielawski J, Gündüz U, Obeid LM, Öğretmen B. Alterations of human longevity assurance gene1 (LASS1)/Sphingosine Kinase-1-dependent ceramide generation and metabolism involve in the regulation of imatinib-induced apoptosis and resistance in K562 human chronic myeloid leukemia. The 41st South Eastern Regional Lipid Conference, November 1-3 2006, Cashiers, NC, USA, p.50.
2006
Baran Y, Gündüz U, Öğretmen B. The sequence analyses of imatinib mesylate binding site of Abl kinase domain in sensitive and imatinib-resistant human CML cells. Balkan J of Medical Genetics, 7th Balkan Meeting on Human Genetics, August 31-September 2 2006, Scopje, Macedonia p.128.
2006
Baran Y, Gündüz U, Bielawski J, Öğretmen B. Circumventing multi-drug resistance by a combination therapy of imatinib and GCS inhibitor in resistant human chronic myeloid leukemia cells. Balkan J of Medical Genetics, 7th Balkan Meeting on Human Genetics, August 31-September 2 2006, Scopje, Macedonia, p.127.
2006
Baran Y, Gündüz U, Ural AU, Öğretmen B. Apoptotic pathways induced by imatinib in sensitive and imatinib-resistant K562 cells. Balkan Journal of Medical Genetics, 7th Balkan Meeting on Human Genetics, August 31-September 2 2006, Scopje, Macedonia, p.127.
2006
Baran Y, Gündüz U, Şenkal BE, Bielawski J, Öğretmen B. The involvement of ceramides in imatinib induced apoptosis and drug resistance. Balkan journal of Medical Genetics, 7th Balkan Meeting on Human Genetics, August 31-September 2 2006, Scopje, Macedonia, p.44.
2006
Baran Y, Ural AU, Öğretmen B, Gündüz U. Multidrug resistance mechanisms in human chronic myeloid leukemia cells. Haematologica, 11th Congress of European Hematology Association, June 15-18 2006, Amsterdam, Netherlands,16.
2006
Baran Y, Şenkal CE, Bielawski J, Öğretmen B, Gündüz U. The involvement of C:18 ceramide and human longevity assurance genes in imatinib induced apoptosis. Haematologica, 11th Congress of European Hematology Association, June 15-18 2006, Amsterdam, Netherlands, p.124.
2006
Baran Y, Şenkal CE, Bielawski J, Öğretmen B, Gündüz U. Ceramide glycosylation by glucosyl ceramide synthase inhibits the apoptotic effect imatinib on human K562 and Meg-01 cells. Haematologica, 11th Congress of European Hematology Association, June 15-18 2006, Amsterdam, Netherlands, p.125.
2006
Baran Y, Şenkal CE, Bielawski J, Öğretmen B, Gündüz U. Overcoming the chemoresistance in human chronic myeloid leukemia K562 cells by siRNA inhibition of sphingosine kinase-1. Haematologica, 11th Congress of European Hematology Association, June 15-18 2006, Amsterdam, Netherlands, p.15.
2005
Avcu F, Ural AU, Baran Y, Sobacı G, Deveci M, Çetin A, Pekel A, Sarper M, Elçi P, Gündüz U. A photodynamic pathway to apoptosis induced by hypericin in human myeloma ARH-77 cell line: Possible relevance to photodynamic therapy. The 47th American Society of Hematology Annual Meeting and Exposition, 2005, p.351B.
2005
Kars DM, İşeri DÖ, Atalay C, Baran Y, Kaya P, Gündüz U. Investigation of molecular mechanisms of multiple drug resistance in different cell lines and tissue types. The European COST action B16 Symposium on Multidrug Resistance Reversal, May 13-14 2005, Antalya, Turkey, p.35.
2004
Baran Y, Gündüz U, Ural AU. Investigations of cross-resistance to cytarabine in human promyelocytic leukemia cell line selected for resistance to Vincristine. 6th Balkan Meeting on Human Genetics, August 28-31 2004, Thessaloniki, Greece, p.66